摘要
目的探讨B超引导下注射平阳霉素和(或)消痔灵治疗肝血管瘤的临床价值。方法该院2000年10月￣2005年10月收治的27例肝血管瘤患者采用B超引导下瘤体内注射平阳霉素和(或)消痔灵。肿瘤直径<4cm的不予治疗;直径4￣6cm的肿瘤单独注射平阳霉素;直径≥6cm的肿瘤注射平阳霉素和消痔灵两组药物。结果全组27例患者,共39个肿瘤,治疗35个,根据疗效评定标准,治愈23个(65.7%),显效8个(22.8%),有效3个(8.6%),无效1个(2.9%),总有效率97.1%。穿刺治疗后3例出现发热,2例退针后出现穿刺部位灼痛。所有病例无出血、胆瘘及其他严重并发症。结论B超引导下经皮肝穿刺注射平阳霉素和(或)消痔灵治疗肝血管瘤的方法操作简单、安全有效。
[Objective] To investigate the clinical value of Pingyangmycin and （or） Xiaozhiling for treatment of liver hemangioma under ultrasound guidance. [Methods] The clinical date of 27 cases with liver hemangioma in hospital from October 2000 to October 2005, Pingyangmycin and （or） Xiaozhiling was injected into the tumor of the liver under the ultrasound guidance for percutaneous puncture procedures. The tumors with diameter 〈4 cm were not treated; Pingyangmycin was only injected into the tumors with diameter 4-6 cm; and Pingyangmycin and （or） Xiaozhiling were injected into the tumors with diameter≥6 cm. [Results] Among the 27 cases, there were 39 tumors, 35 of them were treated, according to standard about effect of treatment, 23 （65.7%） were cured, 8 （22.8%） were obviously effective, 3 （8.6%） were effective, 1 （2.9%） were no effect, the total effective rate was 97.1%. After treatment, 3 have fever, 2 have ache on the part of puncture. All cases didn＇t bleed and hadn＇t bile leakage and the other serious complications. [Conclusion] The methods that Pingyangmycin and （or） Xiaozhiling was injected into the tumor of the liver under the ultrasound guidance for percutaneous puncture procedures are simple and effective and safe.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2007年第3期340-342,共3页
China Journal of Modern Medicine
关键词
肝血管瘤
B超
平阳霉素
消痔灵
liver hemangioma
B-model ultrasound
Pingyangmycin
Xiaozhiling
